Philips Healthcare India announces $60 million investment in manufacturing facility

Michael Walter | | Radiology Business | Economics

Philips Healthcare India will invest approximately $60 million into its Pune facility over the next three to five years, the company announced.

The goal of the investment is to increase manufacturing capacity at the facility, which produces cath labs and products related to mobile surgery. 

“Once the capacity is doubled, more and more business lines such as ultrasound machines, CT scans and MRIs will come out of the Pune facility,” Chhitiz Kumar, Philips Capital India CEO, said in a statement.

According to Kumar, Philips has a presence in India of approximately $1 billion, with around $300 million of that coming from the company’s healthcare business. And the numbers are only improving as India’s economy continues to grow.

“We are expecting up to 18% growth in the current fiscal,” Kumar said in the statement. “We have been seeing a double-digit growth year-on-year for the past four to five years.”

Kumar also said there are plans for seven radiology centers to be opened in Haryana. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’
Radiology experts say state Medicaid rates must increase to improve imaging access
Hologic recalling breast care device after 252 injuries, slew of patient lawsuits
Congress reaches deal to partially blunt Medicare pay cut, ditches prior authorization reform
Whole-body MRI startup Prenuvo’s recent ‘milestone’ would mark $250M in revenue

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.